ATE238805T1 - Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält - Google Patents

Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält

Info

Publication number: ATE238805T1
Authority: AT; Austria
Prior art keywords: nicotinic acid; lowering blood; blood cholesterol; acid; fat absorption
Prior art date: 1996-02-14

Application number

AT97904162T

Other languages

English (en)

Inventor

Ivan Furda

Original Assignee

Ivan Furda

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-14

Filing date

1997-02-04

Publication date

2003-05-15

1997-02-04 Application filed by Ivan Furda filed Critical Ivan Furda

2003-05-15 Application granted granted Critical

2003-05-15 Publication of ATE238805T1 publication Critical patent/ATE238805T1/de

Links

PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 title abstract 6
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 4
229920001661 Chitosan Polymers 0.000 title abstract 3
238000009472 formulation Methods 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 3
229960003512 nicotinic acid Drugs 0.000 title abstract 3
235000001968 nicotinic acid Nutrition 0.000 title abstract 3
239000011664 nicotinic acid Substances 0.000 title abstract 3
238000010521 absorption reaction Methods 0.000 title 1
239000008280 blood Substances 0.000 title 1
210000004369 blood Anatomy 0.000 title 1
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract 2
GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 abstract 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract 1
102000015779 HDL Lipoproteins Human genes 0.000 abstract 1
108010010234 HDL Lipoproteins Proteins 0.000 abstract 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
235000010323 ascorbic acid Nutrition 0.000 abstract 1
229960005070 ascorbic acid Drugs 0.000 abstract 1
239000011668 ascorbic acid Substances 0.000 abstract 1
230000009286 beneficial effect Effects 0.000 abstract 1
235000020958 biotin Nutrition 0.000 abstract 1
229960002685 biotin Drugs 0.000 abstract 1
239000011616 biotin Substances 0.000 abstract 1
235000012000 cholesterol Nutrition 0.000 abstract 1
210000001072 colon Anatomy 0.000 abstract 1
229960000304 folic acid Drugs 0.000 abstract 1
235000019152 folic acid Nutrition 0.000 abstract 1
239000011724 folic acid Substances 0.000 abstract 1
210000002429 large intestine Anatomy 0.000 abstract 1
229940055726 pantothenic acid Drugs 0.000 abstract 1
235000019161 pantothenic acid Nutrition 0.000 abstract 1
239000011713 pantothenic acid Substances 0.000 abstract 1
210000002966 serum Anatomy 0.000 abstract 1
229940088594 vitamin Drugs 0.000 abstract 1
235000013343 vitamin Nutrition 0.000 abstract 1
239000011782 vitamin Substances 0.000 abstract 1
229930003231 vitamin Natural products 0.000 abstract 1
-1 vitamin acids Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Obesity (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)

AT97904162T 1996-02-14 1997-02-04 Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält ATE238805T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/601,388 US5736532A (en)	1996-02-14	1996-02-14	Multifunctional fat absorption and blood cholesterol reducing formulation comprising chitosan
PCT/US1997/001635 WO1997029760A1 (en)	1996-02-14	1997-02-04	Multifunctional fat absorption and blood cholesterol reducing formulation containing chitosan and nicotinic acid

Publications (1)

Publication Number	Publication Date
ATE238805T1 true ATE238805T1 (de)	2003-05-15

Family

ID=24407295

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97904162T ATE238805T1 (de)	1996-02-14	1997-02-04	Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält

Country Status (10)

Country	Link
US (1)	US5736532A (de)
EP (1)	EP0881903B1 (de)
JP (1)	JP2000504724A (de)
AT (1)	ATE238805T1 (de)
AU (1)	AU1852597A (de)
DE (1)	DE69721497T2 (de)
ES (1)	ES2199342T3 (de)
ID (1)	ID15895A (de)
WO (1)	WO1997029760A1 (de)
ZA (1)	ZA971134B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR9912627A (pt)	1998-07-30	2002-02-13	Nutriceuticals Inc E	Composição em suspensão lìquida estável, e, processos para preparação e uso da mesma e para tratamento de peso e de colesterol
GB9920393D0 (en) *	1999-08-27	1999-11-03	Medix Scient Uk Limited	Plant extract mixtures and their uses
WO2003013471A2 (en) *	2001-08-08	2003-02-20	Paolina Galvao	Pharmaceutical enteric coated composition comprising chitosan
US6897348B2 (en)	2001-12-19	2005-05-24	Kimberly Clark Worldwide, Inc	Bandage, methods of producing and using same
US7419655B2 (en) *	2002-09-11	2008-09-02	Kimberly-Clark Worldwide, Inc.	Skin care products
GB0302741D0 (en) *	2003-02-06	2003-03-12	Advanced Biopolymers As	Use
RU2232775C1 (ru) *	2003-05-16	2004-07-20	Общество с ограниченной ответственностью "Инвест-Фарм"	Способ получения ионосвязанных производных олигосахарида хитозана
US20070116713A1 (en) *	2005-11-22	2007-05-24	Gill Robert P	Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
KR100882611B1 (ko) *	2006-11-14	2009-02-12	주식회사 키토라이프	표적 리간드로서 폴릭산이 도입된 유전자 전달체용저분자량 수용성 키토산 나노입자 및 이의 제조방법
US7659313B2 (en) *	2007-09-13	2010-02-09	Gateway Health Alliances, Inc.	Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals
CN102469782A (zh)	2010-06-18	2012-05-23	哈洛资源公司	包含壳聚糖的固态共混物的制剂及方法
BR112014030835B1 (pt) *	2012-06-15	2022-01-11	Conaris Research Institute Ag	Composição contendo ácido nicotínico e/ou nicotinamida e/ou triptofano, e uso da mesma
AU2014363430A1 (en) *	2013-12-13	2016-06-16	Conaris Research Institute Ag	A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation
WO2015086843A2 (en)	2013-12-13	2015-06-18	Conaris Research Institute Ag	A pharmaceutical composition containing nicotinic acid and/or nicotinamide for beneficially influencing blood lipid levels by modifying the intestinal microbiota
ITUA20161937A1 (it) *	2016-03-23	2017-09-23	S I I T S R L Servizio Int Imballaggi Termosaldanti	Preparazione per il controllo del peso corporeo a base di chitosano e cellulosa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4223023A (en) *	1978-10-12	1980-09-16	Ivan Furda	Nonabsorbable lipid binder
US5300494A (en) *	1986-06-06	1994-04-05	Union Carbide Chemicals & Plastics Technology Corporation	Delivery systems for quaternary and related compounds
US4946870A (en) *	1986-06-06	1990-08-07	Union Carbide Chemicals And Plastics Company Inc.	Delivery systems for pharmaceutical or therapeutic actives
JP2667351B2 (ja) *	1992-03-24	1997-10-27	麒麟麦酒株式会社	食餌脂質消化吸収阻害剤および飲食品
US5420197A (en) *	1994-01-13	1995-05-30	Hydromer, Inc.	Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives

1996
- 1996-02-14 US US08/601,388 patent/US5736532A/en not_active Expired - Lifetime
1997
- 1997-02-04 AT AT97904162T patent/ATE238805T1/de not_active IP Right Cessation
- 1997-02-04 EP EP97904162A patent/EP0881903B1/de not_active Expired - Lifetime
- 1997-02-04 JP JP9529372A patent/JP2000504724A/ja active Pending
- 1997-02-04 ES ES97904162T patent/ES2199342T3/es not_active Expired - Lifetime
- 1997-02-04 AU AU18525/97A patent/AU1852597A/en not_active Abandoned
- 1997-02-04 DE DE69721497T patent/DE69721497T2/de not_active Expired - Fee Related
- 1997-02-04 WO PCT/US1997/001635 patent/WO1997029760A1/en not_active Ceased
- 1997-02-06 ID IDP970367A patent/ID15895A/id unknown
- 1997-02-11 ZA ZA9701134A patent/ZA971134B/xx unknown

Also Published As

Publication number	Publication date
DE69721497D1 (de)	2003-06-05
ID15895A (id)	1997-08-14
AU1852597A (en)	1997-09-02
EP0881903B1 (de)	2003-05-02
ES2199342T3 (es)	2004-02-16
EP0881903A1 (de)	1998-12-09
ZA971134B (en)	1997-08-25
WO1997029760A1 (en)	1997-08-21
JP2000504724A (ja)	2000-04-18
DE69721497T2 (de)	2004-03-18
US5736532A (en)	1998-04-07

Similar Documents

Publication	Publication Date	Title
ATE238805T1 (de)	2003-05-15	Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält
DE69822832D1 (de)	2004-05-06	Therapeutische und lebensmittel-zusammensetzungen, welche essentielle fettsäuren und bioaktive disulfide enthalten
FR2634376B1 (fr)	1992-04-17	Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
MXPA01013210A (es)	2004-06-03	Composiciones farmaceuticas y nutricionales que contienen acidos grasos esenciales y agentes que disminuyen en la homocisteina.
BR9810547A (pt)	2000-08-15	Absorção de minerais pelas células intestinais
MY116272A (en)	2003-12-31	Immunity enhancing lactic acid bacteria
GB9312853D0 (en)	1993-08-04	Chemical compounds
EP0903143A3 (de)	1999-05-06	Verwendung von Daidzein zur Herstellung eines Arzneimittels zur Erhöhung des HDL Cholesterolniveaus
GB8524276D0 (en)	1985-11-06	Pharmaceutical & dietary compositions
ATE215320T1 (de)	2002-04-15	Nahrungszusammensetzungen in verschiedenen formen
CA2136614A1 (en)	1993-12-23	Nitrous oxide containing dermatological composition
AU5079600A (en)	2001-06-04	Composition comprising ozonized oils and/or other ozonized natural and/or synthetic products and their use in pharmaceutical, cosmetic, dietetic or food supplement compositions in human and veterinary medicine
ZA948669B (en)	1995-07-04	New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
CA2387787A1 (en)	2001-04-12	Nutritional composition for treating inflammatory bowel diseases
CA2271162A1 (en)	1997-12-11	Stearidonic acid compositions and uses thereof
GR3035613T3 (en)	2001-06-29	Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
DE69501105D1 (de)	1998-01-08	L-Carnitin-Salz, dieses enthaltende kosmetische und pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
SE9801647D0 (sv)	1998-05-12	Therapeutic composition
EP0344997A3 (de)	1990-09-26	Verwendung von Phytinsäure oder eines ihrer Salze als Aktivator für hypoxysche Zellen und als Durchblutungsförderer
TR200100897T2 (tr)	2001-10-22	Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri.
DE69826270D1 (de)	2004-10-21	Zinc und linolsäure enthaltendes nährungsmittel
JPS6467164A (en)	1989-03-13	Nutritional composition for old people
FR2658190B1 (fr)	1992-06-05	Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant.
BR9611609A (pt)	1999-12-28	Composição dietética que pode ser absorvida, capaz de melhorar equilìbrio biológico da flora do trato intestinal
AU3992897A (en)	1998-04-09	Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders

Legal Events

Date	Code	Title	Description
2003-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties